Medical Coding Training Center in Trivandrum

                                                       D61.82 Mtelophythisis



 Myelophthisic anemia is a normocytic, normochromic anemia that occurs when normal marrow space is infiltrated and replaced by nonhematopoietic or abnormal cells. Causes include tumors, granulomatous disorders, lipid storage diseases, and primary myelofibrosis. Bone marrow fibrosis often occurs as a secondary process as well. Splenomegaly may develop. Characteristic changes in peripheral blood include anisocytosis, poikilocytosis, and excessive numbers of red blood cell and white blood cell precursors. Diagnosis usually requires bone marrow biopsy. Treatment is supportive and includes measures directed at the underlying disorder.

Myelofibrosis is an uncommon type of bone marrow cancer that disrupts your body's normal production of blood cells.Myelofibrosis causes extensive scarring in your bone marrow, leading to severe anemia that can cause weakness and fatigue. Bone marrow scarring can also cause you to have a low number of blood-clotting cells called platelets, which increases the risk of bleeding. Myelofibrosis often causes an enlarged spleen.Myelofibrosis is considered to be a chronic leukemia — a cancer that affects the blood-forming tissues in the body. Myelofibrosis belongs to a group of diseases called myeloproliferative disorders.

Myelofibrosis can happen on its own (primary myelofibrosis) or it can develop from another bone marrow disorder (secondary myelofibrosis).Some people with myelofibrosis have no symptoms and might not need treatment right away. Others with more-serious forms of the disease might need aggressive treatments right away. Treatment for myelofibrosis, which focuses on relieving symptoms, can involve a variety of options.

The most common cause of myelophthisic anemia is

  • Replacement of bone marrow by metastatic cancer

Cancers most often involved include breast or prostate; less often kidney, lung, adrenal, or thyroid cancers are the cause. Extramedullary hematopoiesis tends to be modest.

Other causes include myeloproliferative disorders such as primary myelofibrosis or myelofibrosis evolving from polycythemia vera or essential thrombocythemia , granulomatous diseases, and lipid storage diseases such as Gaucher disease or other causes of marrow fibrosis.




Symptoms and signs

Myeloid metaplasia may result in splenomegaly, particularly in patients with storage diseases. In severe cases, symptoms of anemia and of the underlying disorder may be present. Massive splenomegaly can cause abdominal pressure, early satiety, cachexia, portal hypertension , and left upper quadrant abdominal pain; hepatomegaly may be present. Hepatosplenomegaly is rare with myelofibrosis due to malignant tumors.

Diaganosis

  • Complete blood count (CBC), red blood cell (RBC) indices, reticulocyte count, and peripheral smear

  • Bone marrow examination

Myelophthisic anemia is suspected in patients with normocytic anemia, particularly when splenomegaly or a potential underlying cancer is present. If it is suspected, a peripheral smear should be done, because a leukoerythroblastic pattern (immature myeloid and erythroid cells such as myelocytes and metamyelocytes, and normoblasts or other nucleated RBCs) suggests myelophthisic anemia. Extramedullary hematopoiesis or disruption of the marrow sinusoids causes release of immature myeloid cells and nucleated red cells into the periphery. Abnormally shaped RBCs, typically teardrop-shaped (dacrocytes), are also present.

Anemia, usually moderate to severe, is characteristically normocytic but may be slightly macrocytic. RBC morphology may show extreme variation (anisocytosis and poikilocytosis) in size and shape. The white blood cell count may vary. The platelet count is often low, and platelets are often large and bizarre in shape.

Although examination of peripheral blood can be suggestive, diagnosis usually requires bone marrow examination . Indications include a leukoerythroblastic pattern and unexplained splenomegaly. The marrow may be difficult to aspirate; marrow trephine biopsy is usually required. Findings vary according to the underlying disorder. Erythropoiesis is normal or increased in some cases. Hematopoiesis may be present in the spleen and liver.

X-rays, if obtained incidentally, may disclose bony lesions (myelosclerosis) characteristic of long-standing myelofibrosis or other osseous changes (ie, osteoblastic or lytic lesions of a tumor), suggesting the cause of anemia.

Treatment

  • Treatment of underlying disorder

  • Transfusions as needed

The underlying disorder is treated. Management is supportive with transfusions .


                                          TRANSORZE SOLUTION

       Digital Marketing, Medical Coding, Medical Scribing ,MedicalTranscription

                                                               OET Training

                                                        Contact: 094958 33319


Comments

Popular posts from this blog

Top Medical Coding Institute in Trivandrum

Medical Coding Training Institute in Trivandrum

Top Medical Coding Institute and Training center in Trivandrum